Four faculty in the WDOM have received the ASCI Council Young Physician-Scientist Award. This prestigious award recognizes physician-scientists who are early in their first faculty appointment and have made notable achievements in their research.
Dr. Dadhania will be responsible for ensuring the operation and compliance of the transplant program, and will collaborate with NYP leadership to facilitate optimal care of transplant candidates and recipients.
A team of intercampus investigators has received a $3.65 million grant from the NIH to develop an inexpensive method for accurately diagnosing UTIs in kidney transplant patients by carrying out molecular profiling of cell-free DNA in urine.
In this paper, which reflected further analysis stemming from their previous paper published in Nature Communications (December 2019), 168 kidney transplant recipients, who provided 510 fecal specimens, were evaluated.
The CHAP project is a large multicenter pragmatic randomized trial that is comparing two different strategies for managing hypertension during pregnancy in women who had elevated blood pressure prior to pregnancy.
Until now, vital data had been lacking on graft and patient outcomes in kidney transplant recipients and the management of their immunosuppression in the setting of Covid-19.
This award is presented annually to members of the Weill Department of Medicine below the rank of professor who perform on outstanding levels in the areas of clinical and/or basic biomedical research.
Initiated in 2002, the award is given to fellows within the Weill Department of Medicine who have performed outstanding research. This year's finalists were presented at Medicine Grand Rounds on June 17.
In a collaborative study, Dr. John R. Lee and colleagues revealed a first-of-its-kind discovery showing that the abundance of uropathogens in the gut is associated with future development of UTI.
Dr. Suthanthiran's talk was entitled “Monitoring the Allograft in the 21st Century: From the Microscope to Molecular Scan.”